Radioimmunolocalization of tumours in patients, after administration of radio-iodinated primary antibodies to tumour products, has been demonstrated by external scintigraphy (Goldenberg et al., 1980; Mach et al., 1980; Searle et al., 1980) . However, discrimination is impaired by the proportion of labelled antibody remaining in the patient's circulation at the time of scanning and a blood pool subtraction technique using technetium-labelled albumin and pertechnetate is necessary. Since intravenouslyinjected liposomes are rapidly accumulated by the reticuloendothelial system (Gregoriadis & Ryman, 1972) and liposomes have been shown to be effective in removing circulating digoxin (Campbell et al., 1980) , clearance of radiolabelled primary antibody from the circulation in animal models was investigated using liposomally-entrapped antibody to the primary immunoglobulin (entrapped secondary antibody).
Goat primary antibody (PKIG, D2, Keep et al., 1978) was raised to carcinoembryonic antigen, immunopurified (Searle et al., 1980) , and the anti-(carcinoembryonic antigen) y-globulins were labelled with 1251 in ice by the chloramine--r technique (after Hunter & Greenwood, 1962) . The y-globulin fraction of horse anti-goat secondary antibody (BW 402, gift of antiserum from Burroughs Wellcome) was obtained by (NHJ2S0, precipitation and DEAE-Sephadex gel chromatography.
Negatively charged liposomes were prepared by the method of Gregoriadis & Ryman (1972) with egg phosphatidylcholine, cholesterol and phosphatidic acid in the molar ratio 9 :9 :2 and 5 mwphosphate buffer, pH 7.4, containing 9 g of NaCI/I and lOmg of secondary antibody/ml. In some experiments [3Hlcholesterol was added as a marker of liposomal lipid. The liposomes were sonicated for 10min with cooling and free secondary antibody was separated from liposomally-entrapped protein by gel filtration on Sephadex 6B-CL. In preliminary experiments a trace of 1251-labelled secondary antibody was added to the aqueous medium. In one experiment the liposome bilayer was labelled with 99mTc by the method of Richardson et al. (1978) .
Liposomes prepared in this way contained 126pg of secondary antibody per pmol of liposomal lipid. The ability of the liposomes to bind primary antibody was determined with the Kemtek automated radioimmunoassay system (Bagshawe, 1974) . Liposomes containing no secondary antibody did not bind primary antibody. The amount of 1251-labelled primary antibody bound by liposomes containing secondary antibody was only 4% of that bound by an equal concentration of secondary antibody free in solution.
Groups of normal AKR mice, or nude mice bearing xenografts of a poorly differentiated human colonic adenocarcinoma (TAF, Lewis & Keep, 1981) were given intravenous injections of '251-labelled primary antibody: 24 h later half the animals received liposomes containing secondary antibody intravenously (3-27pmol of lipid as liposomes in 0.1-0.2ml), the rest remained as controls. Mice were killed at intervals up to 24 h after injection of liposomes, tissues were removed and the distribution of 1251-labelled primary antibody was determined. Less l Z 5 I activity was present in the blood of liposome-treated mice than in the blood of controls at 30min and at all subsequent times after liposome injection. In animals given liposome-entrapped secondary antibody (lOpmol of lipid), the blood radioactivity was 25-30% of that in controls, and in animals given 27pmol of lipid the blood radioactivity was only 5% of the control 24 h after treatment. 1251-labelled anti-(carcino embryonic antigen) activity accumulated in the livers and spleens of liposome-treated mice, but not of control mice, for the first 2h after liposome injection, and thereafter levels of '251 were slowly decreased.
In tumour-bearing mice there was no difference between 1251-labelled primary antibody radioactivity in the tumours of the control group, and the radioactivity in the tumours of mice treated with liposomally-entrapped secondary antibody, up to 6 h after treatment; 24h after liposome injection, the tumour radioactivity in the animals given entrapped secondary antibody was less than in controls. However, the tumour-to-blood ratio of primary antibody was still increased relative to controls.
Markers of the liposomal bilayer, [3H1cholesterol and 99mTc, were removed rapidly from the blood of mice after injection and accumulated in the liver and spleen, as is expected for small negatively-charged liposomes. From the distribution of [3H]cholesterol as a marker of the lipid bilayer, it appeared that liposomes were not accumulated within the tumours.
It therefore appears that liposomes containing secondary antibody have potential use in clearance of radiolabelled antitumour primary antibody from the circulation of patients undergoing external scintigraphy for the detection of tumours. The ratio of primary antibody in the tumour to that in the blood would be increased, and the tumour imaging scans may be improved.
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Many aspects of lymphocyte behaviour are stimulated by interactions at the cell surface, but these interactions are often regulated intracellularly by the cytoskeleton. Thus the lymphocyte cytoskeleton has been implicated in the 'patching' and 'capping' of surface components induced by multivalent ligands, the internalization of receptor-ligand complexes, plasma-membrane recyclization and lymphocyte-cell interactions (Edelman, 1976) . In erythrocytes the cytoskeleton is defined operationally as the insoluble network of spectrin, actin and ankyrin that remains after exhaustively extracting the plasma membrane with non-ionic detergent (Yu et al., 1973; Branton et al., .l981). Cytoskeletal components of other cell types may be revealed by using an identical approach. Indeed, insoluble residues comprising a restricted number of polypeptides including actin have been isolated in this way from the brush borders of intestinal epithelial cells (Bretscher & Weber, 1980) and the plasma membranes of murine tumour and lymphoid cells (Mescher et al., 1981) . In the present study, Nonidet P40-insoluble residues prepared from plasma membranes of cultured human B lymphoblastoid cells (cell-lines Daudi, RPMI 1788, BRI 8 and Maja) and quiescent pig mesenteric lymph-node lymphocytes were characterized morphologically and chemically.
Purified lymphocyte plasma membrane, isolated as described previously (Crumpton & Snary, 1974; Snary et al., 1976) , was extracted (0.5mg of membrane protein/ml) for 30min at O°C with 0.5% Nonidet P40 in Dulbecco's phosphate-buffered saline (containing 1 mM-Ca2+ and 1 mM-Mg2+) with added phenylmethanesulphonyl fluoride (1 mM) and iodoacetamide (IOmM); in some experiments the extraction was carried out in the absence of free Ca2+ and Mg2+ by adding 1 mM-EDTA. The extract was centrifuged for 8 x I05g-min (Beckman L5) and the supernatant was subsequently re-centrifuged for 11.4 x 10bg-min. The first pellet will be referred to as the '20K pellet' and in some cases was washed extensively with 0.5% Nonidet P40 before analysis.
The human and pig 20K pellets contained about 12% and 9% respectively of the original membrane protein. Electron microscopy revealed amorphous material together with, apparently. typical membrane vesicles that possessed the trilaminar structure characteristic of lipid bilayers. Lipid analyses indicated that the pellets had a similar composition (in respect of the ratio of phospholipid to cholesterol and in the relative amounts of the different phospholipids) to that of the plasma membrane, although the pellets contained a lower proportion of protein relative to lipid. The polypeptide compositions of the 20K pellets, as visualized by polyacrylamide-gel electrophoresis in sodium dodecyl sulphate, are shown in Fig. 1 . The human pellets VOl. 9 comprised predominant polypeptides of mol.wts. 67 000 and 45000, major polypeptides of mol.wts. 129000, 34000 and 30000 and several minor bands. The pig pellet possessed a qualitatively similar composition with some distinctive quantitative differences in respect of the bands of mol.wts. 200000, 129000, 67000 and 45000. The 129000-and 67000-mol.wt. bands of the human plasma membrane were located primarily, if not exclusively, in the 20K pellet, but the 45 000-mol.wt. band was present in both pellet and supernatant. As judged by co-migration with authentic proteins the 200000-and 45 000-mol.wt. polypeptides represent myosin and actin respectively. Fig. I(b) shows that the polypeptide composition of the 20K pellet can be altered markedly by depleting the solubilizing solvent of Ca2+ and Mg2+. Under these conditions the 67000, 34000 and 30000-mol.wt. bands were located exclusively in the soluble fraction.
The results suggest that lymphocyte plasma membrane includes a cytoskeleton, as defined by its insolubility in Nonidet P40, that comprises five major polypeptide chains including actin. The presence of lipid in the detergent-insoluble residue is In (a) the gel contained 7.5% polyacrylamide. Plasma membranes from Maja cells, BRI 8 cells and pig lymphocytes (tracks 7, 8 and 9 respectively) were extracted with 0.5% Nonidet P40.
The extracts were centrifuged at 20000rev./min for 30min to give the 20K pellets (tracks 4, 5 and 6 respectively). The supernatants were re-centrifuged at 50000rev./min for 45 min to give the soluble fractions (tracks 1, 2 and 3 respectively). In (b) the gel contained 10% polyacrylamide. Tracks (1) and (2) represent 20K pellets obtained by extracting Maja plasma membrane with Nonidet P40 in the absence and presence respectively of Ca2+ and Mg2+. Both gels were run under reducing conditions and were stained with Coomassie Blue. The numbers to the left ofthe gels represent x molecular weight.
